 SOUTH SAN FRANCISCO, Calif., Jan. 3, 2022 PRNewswire -- IDEAYA Biosciences, Inc. NASDAQ: IDYA, a synthetic lethality focused precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced its participation in investor conferences in January 2022. 